| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2002 | CA2325765A1 Method for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
| 05/01/2002 | CN1347459A Novel substance originating in basidiomycete culture, process for producing same and use thereof |
| 05/01/2002 | CN1347420A Growth hormone secretagogues |
| 05/01/2002 | CN1347418A Novel nucleosides and oligonucleotide analogues |
| 05/01/2002 | CN1347417A 4-oxo-4,7-dihydro-thieno [2,3-b] pyridine-5-carboxamides as antiviral agent |
| 05/01/2002 | CN1347416A Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 05/01/2002 | CN1347415A Tricyclic pyridine N-oxides vasopressin agonists |
| 05/01/2002 | CN1347414A Triazole compounds with dopamine-D3-receptor affinity |
| 05/01/2002 | CN1347413A Crystalline form of omeprazole |
| 05/01/2002 | CN1347408A Use of maduraphthalazine derivs. as inhibitors of pro-inflammatory cytokins |
| 05/01/2002 | CN1347406A Carbamic acid derivs. and their use as metabotropic glutamate receptor ligands |
| 05/01/2002 | CN1347404A (-)-Verbenzone derivs. |
| 05/01/2002 | CN1347398A Salts of asiatic and madecassic acid suitable for preparation of pharmaceutical and cosmetic compositions |
| 05/01/2002 | CN1347328A Dry acid-chitosan complexes |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1347324A Composition for treatment of psoriasis |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 05/01/2002 | CN1347321A Use of vasopeptidase inhibitors to treat angina pectoris |
| 05/01/2002 | CN1347320A Use of cholesterol-lowering agent |
| 05/01/2002 | CN1347319A Agent for improving ketosis |
| 05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
| 05/01/2002 | CN1347317A Remedies |
| 05/01/2002 | CN1347316A Composition for preventing or treating dementia comprising hydroxycinnamic acid deriv. or extract of plant of genus angelicae contg. same |
| 05/01/2002 | CN1347315A Method for producing water-insoluble amorphous or partially amorphous controlled release matrix |
| 05/01/2002 | CN1347314A Controlled release formulation for treating COPD |
| 05/01/2002 | CN1347313A High potency dihydroergotamine compositions |
| 05/01/2002 | CN1347312A Skin preparations |
| 05/01/2002 | CN1347310A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1347309A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1347308A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1347301A Conditioning composition contg. mono and dialkyl quats with silicone |
| 05/01/2002 | CN1346830A Novel 2,4-dioxopyrrolidone and 2,4-dioxotetrahydro-furan derivs. and medicine contg. them as active component |
| 05/01/2002 | CN1346828A Dicyclic aromatic compound and use thereof in human or animal medicine and cosmetic process |
| 05/01/2002 | CN1346673A Chinese patent medicine for treating hyperosteogeny |
| 05/01/2002 | CN1346664A Exterior-applied Chinese-medicinal pill for treating diarrhea |
| 05/01/2002 | CN1346649A Pterygium eliminating liquid |
| 05/01/2002 | CN1346635A Functional nutritive nucleic acid and polyose product and its preparing process |
| 05/01/2002 | CN1346634A Process for preparing miconazole nitrate ointment |
| 05/01/2002 | CN1346633A 利巴韦林脂质体制剂 Ribavirin liposomal formulation |
| 05/01/2002 | CN1083885C Method for producing pravastatin precursor ML-236B |
| 05/01/2002 | CN1083849C Method for preparing polysaccharide gel composition, product obtained thereby and use thereof |
| 05/01/2002 | CN1083848C Fructosan sulfate, its synthesizing process and use thereof |
| 05/01/2002 | CN1083843C 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano [2,3-e] indol-8-ones and derivs., and pharmaceutical compositions thereof |
| 05/01/2002 | CN1083842C [1,2,4] triazolo [4,3-a] quinoxalinone derivs., their preparation and use |
| 05/01/2002 | CN1083840C 8-azabicyclo [3.2.1] oct-2-ene derivs., their preparation and use |
| 05/01/2002 | CN1083838C Novel imidazole derivs., method for preparing same, use as medicine, and pharmaceutical compositions contg. same |
| 05/01/2002 | CN1083834C Nipecotic acid derivs. as antithrombic compounds |
| 05/01/2002 | CN1083833C Sulfur-substd. azetidinone compounds useful as hypocholesterolemic agents |
| 05/01/2002 | CN1083831C Novel tricyclic compounds and drug compositions contg. same |
| 05/01/2002 | CN1083830C Substd. benzamidines, their production and their use as medicaments |
| 05/01/2002 | CN1083717C Extract from leaves of gingko biloba |
| 05/01/2002 | CN1083716C Menstruum for penicillin anaphylaxis intracutaneous test |
| 05/01/2002 | CN1083715C Use of insulin sensitisers for treating renal diseases |
| 04/30/2002 | US6380430 Biphenyl derivatives |
| 04/30/2002 | US6380408 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3 |
| 04/30/2002 | US6380405 Taxane prodrugs |
| 04/30/2002 | US6380403 Illudin analogs useful as antitumor agents |
| 04/30/2002 | US6380398 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv) |
| 04/30/2002 | US6380396 Chemical intermediates for antiinflammatory agents |
| 04/30/2002 | US6380395 Anticancer agents |
| 04/30/2002 | US6380394 Anticancer agents |
| 04/30/2002 | US6380391 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 04/30/2002 | US6380374 Isolated nucleic acid; culture product |
| 04/30/2002 | US6380360 Polycystic kidney disease 1 gene and uses thereof |
| 04/30/2002 | US6380267 Administering a phosphodiesterase inhibitor combined with an additional drug known to decrease sign or symptomatology in a patient with a neurologic condition or disease, or in a patient due to effects of exposure to a drug |
| 04/30/2002 | US6380263 6-substituted pyrimidine 3-oxides for promoting pigmentation of the skin/hair |
| 04/30/2002 | US6380261 Administering to retina antagonist of the nmda receptor-channel complex for therapy of proliferative vitreoretinopathy resulting from penetrating trauma, retinal tear, traction detachment, vitrectomy or intraocular surgery |
| 04/30/2002 | US6380260 Administering 1-(1-(4-chlorophenyl) cyclobutyl)-3-methylbutyl amine derivative to human for decreasing platelet adhesiveness |
| 04/30/2002 | US6380259 Use of substituted amidino compounds in the treatment of chronic obstructive pulmonary disease |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380257 Used as glucose-6-phosphate translocase inhibitors and can be used in therapy of diabetes mellitus |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380254 Administering a mixture of sodium co-transport dependent aminocarboxylic acids to saturate sodium-dependent amino carboxylic acid transport mechanisms of cell plasma membranes; antiischemic, -hypoxic, cardiotonic agents |
| 04/30/2002 | US6380253 Obtaining initial radiographic image of a region containing glioma; injecting into glioma region an anti-angiogenic substance which is linked to sodium salt solution of polyunsaturated fatty acid; obtaining image; evaluation |
| 04/30/2002 | US6380252 Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1 |
| 04/30/2002 | US6380251 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380250 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380248 Metal-thiols as immunomodulating agents |
| 04/30/2002 | US6380244 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/30/2002 | US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus. |
| 04/30/2002 | US6380242 For diagnosis and therapy of central nervous system conditions |
| 04/30/2002 | US6380239 For therapy of arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, inflammatory bowel disease, crohn's disease, ulcerative colitis, systemic lupus erythrematosis, scleroderma, aphthous ulcers, asthma |
| 04/30/2002 | US6380238 Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands |
| 04/30/2002 | US6380236 Method of treating onychomycosis |
| 04/30/2002 | US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy |
| 04/30/2002 | US6380234 Homogenity mixing, granulation, enteric coating |
| 04/30/2002 | US6380232 For therapy of cancer or a viral infection in warm blooded animals, may be used in combination with potentiator or other drug |
| 04/30/2002 | US6380230 For therapy of dyskinesia, obesity, irritable bowel syndrome, diseases whose treatment requires stimulation of the cholecystokinin cck-a receptors |
| 04/30/2002 | US6380228 E.g., n-(2-phenylsulfonyl-1-ethyl)-3-(4-cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/30/2002 | US6380227 Fermentative preparation process for and crystal forms of cytostatics |
| 04/30/2002 | US6380226 For therapy of migraine, cluster headache, chronic paroxysmal hemicrania or headache associated with a vascular disorder, depression, anxiety, an eating disorder, obesity, drug abuse, hypertension and emesis |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380222 Widal syndrone; asthma therapy |
| 04/30/2002 | US6380221 Ortho-anthranilamide derivatives as anti-coagulants |
| 04/30/2002 | US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380217 Methods for controlling GGT-positive bacteria |